Alcohol addiction, gut microbiota, and alcoholism treatment: a review

SC Wang, YC Chen, SJ Chen, CH Lee… - International journal of …, 2020 - mdpi.com
Alcohol addiction is a leading risk factor for personal death and disability. In 2016, alcohol
use caused 2.2% of female deaths and 6.8% of male deaths, and disability-adjusted life …

Alcohol and opioid use, co‐use, and chronic pain in the context of the opioid epidemic: A critical review

K Witkiewitz, KE Vowles - Alcoholism: clinical and experimental …, 2018 - Wiley Online Library
The dramatic increase in opioid misuse, opioid use disorder (OUD), and opioid‐related
overdose deaths in the United States has led to public outcry, policy statements, and funding …

Prevention, screening, and treatment for heavy drinking and alcohol use disorder

J Knox, DS Hasin, FRR Larson, HR Kranzler - The Lancet Psychiatry, 2019 - thelancet.com
Heavy drinking and alcohol use disorder are major public health problems. Practitioners not
specialising in alcohol treatment are often unaware of the guidelines for preventing …

A potential role for the gut microbiome in substance use disorders

KR Meckel, DD Kiraly - Psychopharmacology, 2019 - Springer
Pathological substance use disorders represent a major public health crisis with limited
effective treatment options. While much work has been done to understand the neuronal …

Alcohol use disorder: neurobiology and therapeutics

W Yang, R Singla, O Maheshwari, CJ Fontaine… - Biomedicines, 2022 - mdpi.com
Alcohol use disorder (AUD) encompasses the dysregulation of multiple brain circuits
involved in executive function leading to excessive consumption of alcohol, despite negative …

Role of cannabidiol in the therapeutic intervention for substance use disorders

F Navarrete, MS García-Gutiérrez… - Frontiers in …, 2021 - frontiersin.org
Drug treatments available for the management of substance use disorders (SUD) present
multiple limitations in efficacy, lack of approved treatments or alarming relapse rates. These …

Oxidative stress and neuroinflammation as a pivot in drug abuse. A focus on the therapeutic potential of antioxidant and anti-inflammatory agents and biomolecules

P Berríos-Cárcamo, M Quezada, ME Quintanilla… - Antioxidants, 2020 - mdpi.com
Drug abuse is a major global health and economic problem. However, there are no
pharmacological treatments to effectively reduce the compulsive use of most drugs of abuse …

Evidence-based pharmacotherapies for alcohol use disorder: clinical pearls

J Fairbanks, A Umbreit, BP Kolla, VM Karpyak… - Mayo Clinic …, 2020 - Elsevier
Pathologic alcohol use affects more than 2 billion people and accounts for nearly 6% of all
deaths worldwide. There are three medications approved for the treatment of alcohol use …

Neuroimmune mechanisms of psychostimulant and opioid use disorders

RS Hofford, SJ Russo, DD Kiraly - European Journal of …, 2019 - Wiley Online Library
Substance use disorders are global health problems with few effective treatment options.
Unfortunately, most potential pharmacological treatments are hindered by abuse potential of …

Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review

PV Fischler, M Soyka, E Seifritz… - Frontiers in …, 2022 - frontiersin.org
Compounds known to be successful in the treatment of alcohol use disorder include the
aversive agent, Disulfiram, the glutamatergic NMDA receptor antagonist, Acamprosate, and …